21 May 2009
Ethical consideration of living donor organ transplantation
A TibellAnn Transplant 2009; 14(1): 18-19 :: ID: 880263
Abstract
The use of a live donor as a source for organs for transplantation is a unique act in medicine. With very few exceptions, the basis for medical treatment is the benefit for the individual patient. However, in the case of a live donor, we actually harm - or at least potentially harm - a healthy individual for the benefit of someone else. A free and truly informed consent is the basis for live donation. The potential donor must be capable of understanding the information given and the decision to donate should be voluntary and without coercion. The Amsterdam and Vancouver Fora on live donation establish the responsibility of the transplant team to perform complete medical and psychosocial evaluation and to care for the donor during post-operative recovery. There is also the responsibility to facilitate long-term follow-up and treatment and to identify and track complication. It is recommended that the donor should be evaluated by a different team than the one caring for the recipient. The scarcity of organs is a worldwide problem. No country has a true excess. Still, a global trade in organs has developed with transplant tourism and even trafficking of donors and organs. WHO has estimated that 50,000 kidneys are transplanted yearly worldwide. 20,000 of them are from live donors and the number of trafficked organs is estimated to be between 5,000 and 8,000 per year. A number of scientific gropus have performed psychosocial evaluation of paid donors and the results in Iran, Pakistan and the Philippines are similar. A majority of the donors regret donation and they feel that they have not recovered fully. In the absolute majority of cases, the economical situation one year after donation has not improved. It is important that all countries with transplantation activities have a regulatory framework for live and deceased donation. To lessen the burden on live donors it is likewise important to establish and promote deceased donation globally.
In Press
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860